{"url_path":"/sec/skye/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","accession_number":"0001628280-26-033417","cik":"0001516551","ticker":"SKYE","issuer_name":"Skye Bioscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","primary_entity_key":"0001516551","primary_entity_name":"Skye Bioscience, Inc."},"word_count":51,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\nRule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements\n\nNo officers or directors, as defined in Rule 16a-1(f) under the Exchange Act, adopted and/or terminated a \"Rule 10b5-1 trading arrangement\" or a \"non-Rule 10b5-1 trading arrangement,\" as defined in Regulation S-K Item 408, during the last fiscal quarter.\n\n26"}